niflumic acid

This page covers all niflumic acid drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Chloride channel protein ClC-Ka, Chloride channel protein ClC-Kb, Potassium channel subfamily T member 2.

Targets

Chloride channel protein ClC-Ka, Chloride channel protein ClC-Kb, Potassium channel subfamily T member 2

Phase 2 pipeline (1)

• Niflamol · Neuroscience
  Niflumic acid works by blocking potassium channels to reduce inflammation.

Patent intelligence

• niflumic acid patent landscape — aggregated cliff calendar, attackable patents, originator estates